載入...
Bone marrow-derived NCS-01 cells for ischemic stroke
Stroke stands as one of the most common causes of death among adults worldwide. Currently, tissue plasminogen activator serves as the only approved drug by the Food and Drug Administration for the treatment of acute ischemic stroke. Stem cell therapy serves as a viable treatment option and has been...
Na minha lista:
| 發表在: | Brain Circ |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Wolters Kluwer - Medknow
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8057097/ https://ncbi.nlm.nih.gov/pubmed/34084978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/bc.bc_23_21 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|